134 related articles for article (PubMed ID: 9574332)
1. [Efficient ambulatory and post-discharge thromboprophylaxis with fully automated pens].
Höntzsch D; Scheffer J; Hafner S
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1060-2. PubMed ID: 9574332
[TBL] [Abstract][Full Text] [Related]
2. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
Lassen MR; Borris LC
Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
[TBL] [Abstract][Full Text] [Related]
4. [Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].
Kock HJ; Schmit-Neuerburg KP; Hanke J; Hakmann A; Althoff M; Rudofsky G; Hirche H
Chirurg; 1993 Jun; 64(6):483-91. PubMed ID: 8395380
[TBL] [Abstract][Full Text] [Related]
5. [Fully automated injection pen for prevention of thrombosis. Tolerance, convenience and patient compliance].
Höntzsch D; Scheffer J; Hafner S; Spannagel U; Tolle A
MMW Fortschr Med; 1999 Jul; 141(26):50. PubMed ID: 10897931
[No Abstract] [Full Text] [Related]
6. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
7. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
9. Delivery of low molecular weight heparin for prophylaxis against deep vein thrombosis using a novel, needle-less injection device (J-Tip).
Hollingsworth SJ; Hoque K; Linnard D; Corry DG; Barker SG
Ann R Coll Surg Engl; 2000 Nov; 82(6):428-31. PubMed ID: 11103165
[TBL] [Abstract][Full Text] [Related]
10. [Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
Hamann H
Zentralbl Chir; 1999; 124(1):24-6. PubMed ID: 10091293
[TBL] [Abstract][Full Text] [Related]
11. [Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery].
Schwarz B; Mittelmeier H
Aktuelle Traumatol; 1988 Oct; 18(5):226-32. PubMed ID: 2907248
[TBL] [Abstract][Full Text] [Related]
12. Long-term thromboprophylaxis in practice: how can it be implemented?
Nurmohamed MT; MacGillavry MR
Orthopedics; 2000 Jun; 23(6 Suppl):s647-50. PubMed ID: 10875430
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A
Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
[TBL] [Abstract][Full Text] [Related]
14. Prevention and therapy of postoperative thrombosis and embolism.
Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
[No Abstract] [Full Text] [Related]
15. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
Turpie AG
Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
[No Abstract] [Full Text] [Related]
16. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of thrombosis with fraxiparin 0.3 after ambulatory surgery].
Schain FH
Fortschr Med; 1996 Apr; 114(12):149-52. PubMed ID: 8682431
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
[TBL] [Abstract][Full Text] [Related]
19. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
20. [Thrombophlebitis: bed rest or walking exercise?].
Partsch H
Wien Med Wochenschr; 1999; 149(2-4):50-3. PubMed ID: 10378323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
